GT Biopharma
GTBP
GTBP
20 hedge funds and large institutions have $222K invested in GT Biopharma in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
69% less capital invested
Capital invested by funds: $711K → $222K (-$489K)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83.5K | |
| 2 | +$23.6K | |
| 3 | +$10K | |
| 4 |
Morgan Stanley
New York
|
+$5.87K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$735 |
Top Sellers
| 1 | -$94.2K | |
| 2 | -$5.91K | |
| 3 | -$1.87K | |
| 4 |
MYIA
Mount Yale Investment Advisors
Denver,
Colorado
|
-$165 |
| 5 |
FRA
Front Row Advisors
Tiburon,
California
|
-$4 |
